| 2025-12-16 |
股东大会：
将于2026-01-30召开股东大会
会议内容 ▼▲
- 1.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the “Series A-1 Proposal”);
2.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the “Series C-1 Proposal”);
3.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the “July Warrant Proposal”);
4.To approve the Company’s 2025 Employee Stock Purchase Plan (the “ESPP”) (the “ESPP Proposal”);
5.To approve an amendment to our 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of common stock issuable thereunder to 350,000 shares from 3 shares (the “Equity Incentive Proposal”);
6.To consider and cast a non-binding, advisory vote on the Company’s proposed amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to change the Company’s name from “Aditxt, Inc.” to “bitXbio, Inc.” (the “Name Change Proposal”);
7.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our board of directors in its sole discretion; (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Split Proposal”);
8.To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals (the “Adjournment Proposal”);
9.To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.
|
| 2025-12-16 |
详情>>
股本变动：
变动后总股本177.60万股
|
| 2025-12-01 |
复牌提示：
2025-12-01 10:47:26 停牌，复牌日期 2025-12-01 10:52:26
|
| 2025-11-18 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1605.17美元,归母净利润-3701.25万美元,同比去年增长-5.37%
|
| 2025-10-29 |
详情>>
拆分方案：
每113.0000合并分成1.0000股
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-9.22美元,归母净利润-1296.71万美元,同比去年增长41.80%
|
| 2025-08-08 |
股东大会：
将于2025-09-16召开股东大会
会议内容 ▼▲
- 1.To elect five members to our board of directors;
2.To ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our board of directors in its sole discretion; (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Split Proposal”);
4.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-8.12美元,归母净利润-571.03万美元,同比去年增长61.23%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-3062.51美元,归母净利润-4035.35万美元,同比去年增长-23.4%
|
| 2025-03-17 |
详情>>
拆分方案：
每250.0000合并分成1.0000股
|
| 2025-01-27 |
股东大会：
将于2025-02-28召开股东大会
会议内容 ▼▲
- 1.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the “Series A-1 Proposal”);
2.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the “Series C-1 Proposal”);
3.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the “July Warrant Proposal”);
4.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our board of directors in its sole discretion; (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Stock Split Proposal”);
5.To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals (the “Adjournment Proposal”);
6.To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.
|
| 2024-11-18 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-522.86美元,归母净利润-3512.69万美元,同比去年增长-62.78%
|
| 2024-10-15 |
详情>>
内部人交易：
HRT FINANCIAL LP共交易2笔
|
| 2024-10-02 |
详情>>
拆分方案：
每40.0000合并分成1.0000股
|
| 2024-08-19 |
详情>>
业绩披露：
2024年中报每股收益-13.05美元,归母净利润-2227.93万美元,同比去年增长-90.96%
|
| 2024-07-05 |
股东大会：
将于2024-08-07召开股东大会
会议内容 ▼▲
- 1.To elect five members to our board of directors;
2.To ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series B-1 Convertible Preferred Stock originally issued by the Company in January 2024 (the “Series B-1 Proposal”);
4.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series B-2 Convertible Preferred Stock originally issued by the Company in December 2023 (the “Series B-2 Proposal”);
5.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock under the Company’s equity line of credit pursuant to the Company’s Common Stock Purchase Agreement with an equity line investor pursuant to which such investor has agreed to purchase from the Company from time to time shares of common stock having a total maximum aggregate purchase price of $150 million (the “ELOC Proposal”);
6.To approve an increase to the number of authorized shares of common stock of the Company from 100,000,000 shares to 1,000,000,000 shares (the “Authorized Share Increase Proposal”);
7.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred (1:200) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Split Proposal”);
8.To approve an amendment to our 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of common stock issuable thereunder to 500,000 shares from 37,500 shares;
9.To authorize the adjournment of the Annual Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Annual Meeting or adjournment or postponement thereof to approve any of the foregoing proposals;
10.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2024-05-20 |
详情>>
业绩披露：
2024年一季报每股收益-9.14美元,归母净利润-1472.97万美元,同比去年增长-146.12%
|
| 2024-04-16 |
详情>>
业绩披露：
2023年年报每股收益-108.15美元,归母净利润-3270.07万美元,同比去年增长-18.11%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-136.94美元,归母净利润-2157.98万美元,同比去年增长-10.85%
|
| 2023-08-18 |
详情>>
拆分方案：
每40.0000合并分成1.0000股
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-2.17美元,归母净利润-1166.67万美元,同比去年增长2.04%
|
| 2023-07-20 |
股东大会：
将于2023-08-16召开股东大会
会议内容 ▼▲
- 1.To elect five (5) members to our board of directors;
2.To ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying warrants originally issued by the Company in August 2022;
4.To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying secured promissory notes originally issued by the Company in July 2023;
5.To seek authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d);
6.To approve any change of control under NASDAQ Marketplace Rule 5635 that may result from the potential issuance of securities in the non-public offerings;
7.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred (1:200) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders;
8.To approve an amendment to our 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of common stock issuable thereunder to 1,500,000 shares from 60,000 shares;
9.To authorize the adjournment of the Annual Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Annual Meeting or adjournment or postponement thereof to approve any of the foregoing proposals;
10.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2022-10-21 |
股东大会：
将于2022-11-11召开股东大会
会议内容 ▼▲
- 1.To approve, for the purposes of Listing Rule 5635(d) of The Nasdaq Stock Market LLC (“Nasdaq”), the issuance of shares of common stock underlying warrants originally issued by the Company in August 2022;
2.To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.
|
| 2022-09-14 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2022-08-17 |
股东大会：
将于2022-09-07召开股东大会
会议内容 ▼▲
- 1.To amend our amended and restated certificate of incorporation to increase the number of shares of authorized common stock from 100,000,000 to 150,000,000;
2.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-fifty (1-for-50) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders;
3.To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.
|
| 2022-08-01 |
股东大会：
将于2022-08-16召开股东大会
会议内容 ▼▲
- 1.To amend our amended and restated certificate of incorporation to increase the number of shares of authorized common stock from 100,000,000 to 150,000,000;
2.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-fifty (1-for-50) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders;
3.To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.
|
| 2022-05-10 |
股东大会：
将于2022-06-24召开股东大会
会议内容 ▼▲
- 1.To elect five (5) members to our board of directors;
2.To ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To amend our amended and restated certificate of incorporation to increase the number of shares of authorized common stock from 100,000,000 to 150,000,000;
4.To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-fifty (1-for-50) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders;
5.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-05 |
股东大会：
将于2021-05-19召开股东大会
会议内容 ▼▲
- 1.To elect six (6) members to our board of directors;
2.To ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To approve the Company’s 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) and the reservation of 3,000,000 shares of common stock for issuance thereunder;
4.To amend our amended and restated certificate of incorporation to increase the number of shares of authorized common stock from 27,000,000 to 100,000,000;
5.To approve, for the purposes of Listing Rule 5635 of The Nasdaq Stock Market LLC (“Nasdaq”), the issuance of shares of common stock underlying a Senior Secured Convertible Promissory Note and an accompanying warrant issued by the Company in January 2021 (the “January 2021 Transaction”);
6.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|